Detalhe da pesquisa
1.
Ex vivo organotypic cultures for synergistic therapy prioritization identify patient-specific responses to combined MEK and Src inhibition in colorectal cancer.
Nat Cancer
; 3(2): 219-231, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35145327